alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 31967)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby  given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and  552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential  trade secrets or commercial property such as patentable material, and personal information concerning individuals  associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of  personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel; Community Assessment Rehabilitation Experiment (CARE).                    

*Date:*                         July 28, 2009.                    

*Time:*                         2 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone Conference Call).                    

*Contact Person:*                         Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892-9304, (301) 435-6680,                          *skandasa@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: June 29, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-15788 Filed 7-2-09; 8:45 am]

BILLING CODE 4140-01-P
5S5-/5"

ELECTRONIC RECORD

COA# 04-14-00115-CR

Lloyd Rector v. The State of

STYLE: Texas

COA DISPOSITION: Affirmed

OFFENSE: Aggravated Robbery

COUNTY: Bexar

TRIAL COURT: 227th District Court

DATE:04/15/2015 Publish: NO TCCASE#: 2012CR4029B

IN THE COURT OF CRIMINAL APPEALS

ELECTRONIC RECORD

STYLE: «Style1» v. «Style2» CCA #:

MPJZLL J\NT\*> Petition CCA Disposition: J &5 mtS

FOR DISCRETIONARY REVIEW IN CCA IS: DATE:

SZ&~FO$Bl>i JUDGE:

DATE: 06/M[fT

JUDGE: ^i/Is&ia^-

SIGNED: PC:

PUBLISH: DNP:

MOTION FOR

REHEARING IN CCA IS:

JUDGE:
# Result 22.2
#### Margrie Simmons, Appellant, v Allstate Indemnity Company, Defendant, and James E. Fox Agency, Inc., Respondent.

[975 NYS2d 899]

In an action, inter alia, to recover damages for negligence, the plaintiff appeals, as limited by her brief, from so much of an order of the Supreme Court, Nassau County (Adams, J.), entered March 7, 2012, as, upon reargument, in effect, vacated the determination in an order entered October 6, 2011, denying those branches of the prior motion of the defendant James E. Fox Agency, Inc., which were pursuant to CPLR 3211 (a) to dismiss the causes of action alleging negligent misrepresentation and negligence insofar as asserted against it, and thereupon granted those branches of the motion.

Ordered that the order entered March 7, 2012, is affirmed insofar as appealed from, with costs.

The plaintiff commenced this action against the defendants Allstate Indemnity Company (hereinafter Allstate) and James E. Fox Agency, Inc. (hereinafter the Agency), an Allstate agent, after Allstate disclaimed coverage for property damage resulting from a fire at property owned by the plaintiff. In an order entered March 7, 2012, the Supreme Court, upon reargument, in effect, vacated its determination in a prior order entered October 6, 2011, denying those branches of the Agency’s prior motion which were pursuant to CPLR 3211 (a) to dismiss the causes of action alleging negligent misrepresentation and negligence insofar as asserted against it, and thereupon granted those branches of the motion.

“ ‘A claim for negligent misrepresentation requires the plaintiff to demonstrate (1) the existence of a special or privitylike relationship imposing a duty on the defendant to impart correct information to the plaintiff; (2) that the information was incorrect; and (3) reasonable reliance on the information’ ” *(Stilianudakis v Tower Ins. Co. of N.Y.,*68 AD3d 973, 974 [2009], quoting *J.A.O. Acquisition Corp. v Stavitsky,*8 NY3d 144, 148 [2007]). Here, the plaintiff failed to allege any misrepresentation on the part of the Agency, which procured the insurance policy on her behalf to cover the subject property *(see Stilianudakis v Tower Ins. Co. of N.Y.,*68 AD3d at 974), or the existence of a special relationship with the Agency upon which a cause of action alleging negligent misrepresentation against that defendant could be predicated *(see Mosbacher v JP Morgan Chase Bank, N.A.,*109 AD3d 525 [2013]; *Baer v Complete Off. Supply Warehouse Corp.,*89 AD3d 877, 878 [2011]; *Stilianudakis v Tower Ins. Co. of N.Y.,*68 AD3d at 974).

*612The plaintiffs remaining contention is without merit.

Accordingly, the Supreme Court, upon reargument, properly granted those branches of the Agency’s motion which were to dismiss the causes of action alleging negligent misrepresentation and negligence insofar as asserted against it for failure to state a cause of action. Angiolillo, J.E, Chambers, Roman and Hinds-Radix, JJ, concur.
<PAGE>
EXHIBIT 10.33

                           NON-QUALIFIED STOCK OPTIONS
                                SUMMARY OF TERMS


Date  of  Grant:         February  26,  2001

Exercise  Price:         NYSE  Closing  Price  on  Grant  Date  -  $18.50

Exercisable:             25%  -  February  26,  2004
                         25%  -  February  26,  2005
                         25%  -  February  26,  2006
                         25%  -  February  26,  2007

Expiration  Date:        February  25,  2011

Acceleration:            Award  becomes  fully  exercisable  upon:

                         (a)  Death  of  Optionee  (exercisable  for  three
                              years)
                         (b)  Optionee's  total  and  permanent  disability
                              (exercisable  for  three  years)
                         (c)  Optionee's  voluntary  termination  after  age
                              62  (exercisable  for  three  years)
                         (d)  Involuntary  termination  of  Optionee,  other
                              than  for  cause  (exercisable  for  six  months)
                         (e)  A  change  in  control  of  the  Company
                              (exercisable  for  six  months  after  Optionee's
                              voluntary  or  involuntary  termination
                              following  a  change  in  control)

Forfeiture:              All  shares  not  exercisable  at  the  time  of  the
                         declaration of forfeiture  are  forfeited  upon:

                         (a)  Optionee's  termination  for  cause
                         (b)  Optionee's  voluntary  termination prior to age 62
                         (c)  Optionee  engaging  in  any activity or conduct
                              contrary  to  the  best  interests  of the Company
                         (d)  Optionee  engaging  in  competition  with  the
                              Company

Change  in  Control:     In  a  change  of  control  in which Ralcorp is not the
                         survivor,  recipients  would be entitled to be paid, in
                         cash,  the  spread  between  the  strike  price and the
                         merger  consideration  or  tender  offer  price.
# table17_q4.1_state
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 880 Introduced in House (IH)]

<DOC>

116th CONGRESS
  2d Session
H. RES. 880

Supporting the designation of March 2020 as National Colorectal Cancer 
                            Awareness Month.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 2, 2020

 Mr. Payne (for himself, Mr. Raskin, Mr. Rodney Davis of Illinois, Mr. 
  McEachin, Ms. Jackson Lee, Ms. Norton, Ms. Clarke of New York, Mr. 
    Soto, Mr. Panetta, and Mr. Fitzpatrick) submitted the following 
resolution; which was referred to the Committee on Oversight and Reform

_______________________________________________________________________

                               RESOLUTION

 
Supporting the designation of March 2020 as National Colorectal Cancer 
                            Awareness Month.

Whereas colorectal cancer is the second leading cause of cancer death among men 
        and women combined in the United States;
Whereas in 2020, more than 147,950 Americans will be diagnosed with colorectal 
        cancer and approximately 53,000 Americans will die from it;
Whereas colorectal cancer is one of the most highly preventable forms of cancer 
        because screening tests can find polyps that can be removed before 
        becoming cancerous;
Whereas screening tests can detect colorectal cancer early, when treatment works 
        best;
Whereas the Centers for Disease Control and Prevention estimates that if every 
        individual aged 50 or older had regular screening tests, as many as 60 
        percent of deaths from colorectal cancer could be prevented;
Whereas the 5-year survival rate for patients with localized colorectal cancer 
        is 90 percent, but only 39 percent of all diagnoses occur at this stage;
Whereas colorectal cancer screenings can effectively reduce colorectal cancer 
        incidence and mortality, yet, 1 in 3 adults over 50 years of age are not 
        up to date with recommended colorectal cancer screening;
Whereas public awareness and education campaigns on colorectal cancer 
        prevention, screening, and symptoms are held during the month of March 
        each year; and
Whereas educational efforts can help provide information to the public of 
        methods of prevention and screening, as well as about symptoms for early 
        detection: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the goals and ideals of National Colorectal 
        Cancer Awareness Month; and
            (2) encourages the people of the United States to observe 
        the month with appropriate awareness and educational 
        activities.
                                 <all>
```
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Globalink, Ltd. (the "Company"), hereby
certifies, to such officer's knowledge, that the Company's Quarterly
Report on Form 10-QSB for the three months ended March 31, 2007 (the
"Report") fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that the information contained in
the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

                                 /s/Robin Young
                                 ----------------------
                                 Robin Young
                                 Chief Executive Officer

October 24, 2007

                             CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Globalink, Ltd. (the "Company"), hereby
certifies, to such officer's knowledge, that the Company's Quarterly
Report on Form 10-QSB for the three months ended March 31, 2007 (the
"Report") fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that the information contained in
the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

                                 /s/Ben Choi
                                 ----------------------
                                 Ben Choi
                                 Chief Executive Officer

October 24, 2007
[Federal Register Volume 74, Number 125 (Wednesday, July 1, 2009)]
[Notices]
[Page 31451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15571]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Integrated Pre-Clinical/Clinical 
Program for HIV Topical Microbicides (IPCP-HTM) (U19).
    Date: July 29-30, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Silver Spring, 8727 Colesville Road, Silver 
Spring, MD 20910.
    Contact Person: Betty Poon, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 
301-402-6891, <a href="/cdn-cgi/l/email-protection#067669696864466b676f6a28686f6e28616970"><span class="__cf_email__" data-cfemail="5d2d3232333f1d303c343173333435733a322b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: June 24, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15571 Filed 6-30-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 1057 Considered and Passed Senate (CPS)]

<DOC>

116th CONGRESS
  1st Session
                                S. 1057

   To direct the Secretary of the Interior to execute and carry out 
agreements concerning Colorado River Drought Contingency Management and 
                  Operations, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 8, 2019

    Ms. McSally (for herself, Ms. Cortez Masto, Mr. Barrasso, Mrs. 
Feinstein, Mr. Gardner, Mr. Romney, Ms. Sinema, Mr. Lee, Mr. Enzi, Ms. 
Rosen, Mr. Bennet, Mr. Udall, Mr. Heinrich, and Ms. Harris) introduced 
 the following bill; which was read twice, considered, read the third 
                            time, and passed

_______________________________________________________________________

                                 A BILL

 
   To direct the Secretary of the Interior to execute and carry out 
agreements concerning Colorado River Drought Contingency Management and 
                  Operations, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Colorado River Drought Contingency 
Plan Authorization Act''.

SEC. 2. COLORADO RIVER BASIN DROUGHT CONTINGENCY PLANS.

    (a) In General.--Notwithstanding any other provision of law 
expressly addressing the operation of the applicable Colorado River 
System reservoirs, immediately upon execution of the March 19, 2019, 
versions of the Agreement Concerning Colorado River Drought Contingency 
Management and Operations and the agreements attached thereto as 
Attachments A1, A2, and B, by all of the non-Federal parties thereto, 
the Secretary of the Interior shall, without delay, execute such 
agreements, and is directed and authorized to carry out the provisions 
of such agreements and operate applicable Colorado River System 
reservoirs accordingly.
    (b) Effect.--Nothing in this section shall--
            (1) be construed or interpreted as precedent for the 
        litigation of, or as altering, affecting, or being deemed as a 
        congressional determination regarding, the water rights of the 
        United States, any Indian Tribe, band, or community, any State 
        or political subdivision or district of a State, or any person; 
        or
            (2) exempt the implementation of such agreements and the 
        operation of applicable Colorado River System reservoirs from 
        any requirements of applicable Federal environmental laws.
                                 <all>
```
**Exhibit
      32.2**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of SRKP 10, Inc. (the "Company") on Form
      10-QSB for the period ending March 31, 2007 as filed with the Securities and
      Exchange Commission on the date hereof (the "Report"), I, Anthony C.
      Pintsopoulos, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant
      to
      ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




/s/ Anthony C. PintsopoulosAnthony
              C. PintsopoulosPrincipal
                Financial Officer
              May
                14, 2007
<PAGE>   1








                                  EXHIBIT 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS


We consent to the incorporation by reference in the registration statements of
Atlantis Plastics, Inc. on Form S-8 (Registration Nos. 33-25983 and 33-41012)
of our report dated February 14, 1996 except for Note 7, as to which the date
is February 26, 1996, on our audit of the consolidated financial statements of
Atlantis Plastics, Inc. as of December 31, 1995 and 1994 and for the years
ended December 31, 1995, 1994 and 1993 which report is included in this Form 
10-K.




COOPERS & LYBRAND, L.L.P.




Atlanta, Georgia
March 29, 1996
<PAGE>   1
 
                                                                      EXHIBIT 23
 
                        CONSENT OF INDEPENDENT AUDITORS
 
The Board of Directors
Bay State Gas Company
 
     The audits referred to in our report dated October 22, 1997, included the
related financial statement schedule as of September 30, 1997, and for each of
the years in the three-year period ended September 30, 1997, included in the
annual report on Form 10-K of Bay State Gas Company. This financial statement
schedule is the responsibility of the Company's management. Our responsibility
is to express an opinion on this financial statement schedule based on our
audits. In our opinion, such financial statement schedule, when considered in
relation to the consolidated financial statements taken as a whole, presents
fairly in all material respects the information set forth therein.
 
     We consent to incorporation by reference in the registration statements
(No. 33-39118, and No. 33-44156) on Form S-3 and in the registration statements
(No. 33-35897, No. 33-22300 and No. 33-22301) on Form S-8 of our report dated
October 22, 1997, relating to the consolidated balance sheets and statements of
capitalization of Bay State Gas Company and subsidiaries as of September 30,
1997 and 1996 and the related consolidated statements of earnings, shareholders'
equity and cash flows for each of the years in the three-year period ended
September 30, 1997, which report is included in the September 30, 1997 annual
report on Form 10-K of Bay State Gas Company.
 
                                          KPMG PEAT MARWICK LLP
 
Boston, Massachusetts
December 17, 1997
 
                                       43